Clinical Trials Sponsored by Cerehealth Corp.

Total 914 results

Medigen Vaccine Biologics Corp.

Completed

A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study

Covid19 Vaccine

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine

Enterovirus 71 Infection

Taiwan, Vietnam
Evasc Medical Systems Corp.

Withdrawn

An EFS Assessing the Electrolytic eCLIPs System for Treatment of Intracranial Aneurysms

Aneurysm, Intracranial
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (COVID-19)

Covid19 Vaccine

Taiwan, Vietnam
Anavex Life Sciences Corp.

Completed

ANAVEX2-73 Study in Patients With Rett Syndrome (AVATAR)

Rett Syndrome

Australia, United Kingdom
ApoPharma

Completed

Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload (TWICE)

Iron Overload Due to Repeated Red Blood Cell Transfusions

United States, Canada, Greece, Italy
Shire
Dyax Corp.

Completed

A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects

Hereditary Angioedema (HAE)

United States
Columbia University
Realiteer Corp.

Completed

Virtual Reality Mirror Therapy for Stroke

Stroke

United States
Transdermal Delivery Solutions Corp

Completed

Transdermally Delivered Human Insulin Product

Hypoinsulinemia

United States
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects

H7N9 Influenza Vaccine

Taiwan
Stem Cell Therapeutics Corp.

Terminated

Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS-LED)

Stroke

Canada, India, United States
Stem Cell Therapeutics Corp.

Terminated

REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS)

Stroke

Canada, India
Myant Medical Corp.
McMaster University

Not yet recruiting

Sleep Position Pattern Recording

Pregnant Women

Canada
Sanotize Research and Development corp.

Recruiting

Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute Rhinosinusitis (NONS-RARS-01)

Recurrent Acute Rhinosinusitis

Canada
2C Tech Corp
ORA, Inc.

Not yet recruiting

Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)

Retinitis Pigmentosa
Excelsior
Formosa Biomedical Technology Corp.

Recruiting

A Study of Oral EX039 in Subjects With Mild Alzheimer's Disease

Alzheimer Disease

Taiwan
Perfusio Corp.
University of Rochester

Not yet recruiting

Clinical Testing Study in Peripheral Arterial Disease (CTS-PAD)

Peripheral Arterial Disease
Angion Biomedica Corp
Quotient Sciences

Recruiting

A Study to Assess the Absorption, Metabolism and Excretion of [14C]-ANG-3777

Healthy

United Kingdom
Sanotize Research and Development corp.

Completed

Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)

Verruca Plantaris

Canada
NYU Langone Health
Dyax Corp.

Withdrawn

Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema

Hereditary Angioedema Types I and II

United States
EyeQue Corp.
Eye Boutique Optometry

Completed

Study to Evaluate Visual Acuity Measured With the EyeQue Insight Versus a Standard Eyechart.

Visual Acuity

United States
Global Protection Corp.
Emory University

Completed

Condom Performance in a Longitudinal Enhanced Assessment of User Experiences (C-PLEASURE)

HIV
Johns Hopkins University
Enverdis Corp.

Terminated

Cardiogoniometry for Detecting Coronary Artery Disease by CT Angiography

Coronary Artery Disease | Coronary Heart Disease | Ischemic Heart Disease

United States
Emory University
Synta Pharmaceuticals Corp.

Terminated

Ganetespib Window of Opportunity Study in Head and Neck Cancers

Stage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Laryngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage I Hypopharyngeal Squamous Cell Carcinoma | Stage I Laryngeal Squamous Cell Carcinoma | Stage I Oropharyngeal Squamous Cell Carcinoma | Stage II... and other conditions

United States
Emory University
Synta Pharmaceuticals Corp.

Completed

Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer

Rectal Cancer

United States
Resverlogix Corp
The Cleveland Clinic

Completed

ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation (ASSURE I)

Coronary Artery Disease

Netherlands, Spain, Russian Federation, Belgium, Brazil, Argentina, Poland, Hungary
Jorvec Corp.
University of Miami

Recruiting

CLAD Deconvolved PERG Responses in Glaucoma Patients

Glaucoma, Suspect

United States
University of Pennsylvania
Nlyten Corp

Not yet recruiting

Testing a Wellness App for First Responders, Military Personnel and Veterans

Mental Health Wellness

United States
Sanotize Research and Development corp.

Completed

Nitric Oxide Footbath for Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer

Canada
Sanotize Research and Development corp.

Active, not recruiting

Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection

SARS-CoV-2 Infection

Canada, Sri Lanka
EyeQue Corp.
Eye Boutique Optometry

Completed

A Clinical Study to Evaluate the Remote Monitoring of Myopia Patients With the EyeQue Insight

Myopia

United States
Charsire Biotechnology Corp.
ASKLEP Inc.

Completed

CSTC1 for Diabetic Foot Ulcers Phase II Study

Diabetes Mellitus | Diabetic Foot Ulcer | Wounds

Taiwan
GenomeDx Biosciences Corp
Columbia University

Completed

Multi-site Decision Impact Study for Decipher (ASSESS-D)

Prostate Cancer

United States
Sophiris Bio Corp

Withdrawn

Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1) (CLARITY-1)

Glioblastoma Multiforme
Resverlogix Corp
The Cleveland Clinic

Completed

The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation (SUSTAIN)

Coronary Artery Disease | Dyslipidemia

South Africa
Sophiris Bio Corp

Completed

An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy

Locally Recurrent Prostate Cancer

United States
Sanotize Research and Development corp.

Recruiting

Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis

Candidiasis, Oral

Canada
EyeQue Corp.
Sheba Medical Center

Recruiting

Study in Pediatric Volunteers of a Handheld Device Versus a Standard Diagnostic Device in Ophthalmic Refraction

Refractive Errors | Accomodation | Diagnostic Self Evaluation

Israel
Angion Biomedica Corp
Quotient Sciences

Not yet recruiting

Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval

Healthy Volunteer

United States
Dr. Chandran Medical Prof Corp

Recruiting

The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery

Hematoma Postoperative

Canada
GenomeDx Biosciences Corp
Veracyte, Inc.

Enrolling by invitation

Decipher Genomics Resource for Intelligent Discovery (GRID®)

Prostate Cancer | Bladder Cancer | Renal Cancer

United States
Sanotize Research and Development corp.

Completed

Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)

Chronic Sinusitis

Canada
University of Alberta
Sernova Corp

Terminated

A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation

Type I Diabetes

Canada
Sanotize Research and Development corp.

Withdrawn

Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection

SARS-CoV Infection
McMaster University
MediPharm Labs Corp

Withdrawn

Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

Generalized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | Agoraphobia

Canada
Georgetown University
Synta Pharmaceuticals Corp.

Terminated

A Phase I/II Study of Ganetespib in Combination With Doxorubicin

Cancer | Small Cell Lung Cancer

United States
National Center for Telehealth and Technology
The Geneva Foundation

Completed

Comparing Virtual Reality Exposure Therapy to Prolonged Exposure (VRPE Extension)

Post-Traumatic Stress Disorder | Stress Disorders

United States
Cork University Hospital
University College Cork

Completed

Trans-perineal Trigger Point Dry Needling for Chronic Pelvic Pain

Dyspareunia

Ireland
University College Cork
Cork University Hospital

Completed

The BabyGrow Longitudinal Study of Nutrition and Growth in Preterm Infants (BabyGrow)

Premature Birth of Newborn | Malnutrition; Intrauterine or Fetal, Small-for-dates
CORD, LLC

Terminated

Clinical Trial to Evaluate the Model SC9 IOL Compared to the Model LI61SE IOL (Bausch & Lomb)

Cataract

United States

Clinical Trials Sponsored by Cerehealth Corp.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations